Trypanosoma cruzi is the etiological agent of Chagas' disease, a chronic illness characterized by progressive cardiomyopathy and/or denervation of the digestive tract. The parasite surface is covered with glycoconjugates such as mucin-type glycoproteins and glycoinositolphospholipids (GIPL) whose glycans are rich in galactopyranose (Galp) and/or galactofuranose (Galf) residues. These molecules have been implicated in attachment of the parasite to and invasion of mammalian cells, and in modulation of the host immune responses during infection. In T. cruzi, galactose (Gal) biosynthesis depends on the conversion of UDP-glucose (Glc) into UDP-Gal by an NAD-dependent reduction catalysed by UDP-Gal 4-epimerase.
Introduction
Chagas' disease, a human infection caused by the protozoan parasite T. cruzi is a chronic illness characterized by progressive cardiomyopathy and/or degeneration of the smooth muscle and neurons of the digestive tract (Tyler and Miles, 2003) . T. cruzi is a dixenic parasite alternating between two major life stages in each host: in the insect vector, epimastigotes (replicative and non-infective) differentiate into metacyclic trypomastigotes (non-replicative and infective), which are transmitted to mammals upon their release in the skin after the blood meal. Subsequently, metacyclics may invade diverse cell types in the mammalian host, and transform into amastigotes that undergo several cycles of binary division in the cell cytoplasm. After 3-5 days, amastigotes differentiate into trypomastigotes, which may be released into the blood or adjacent tissues (Brenner, 1973) .
The surface of T. cruzi is covered by a dense coat of antigenic, highly O-glycosylated sialoglycoproteins of the mucin-type in which, uniquely, the glycan chains are linked to, principally, threonine (Thr) residues in the peptide through an -linked N-acetylglucosamine (GlcNAc) unit (rather than N-acetylgalactosamine (GalNAc)) (Previato et al., 1994; . The GlcAc unit can be substituted by Gal residues in either their pyranoside or furanoside forms (Previato et al., 1994; Todeschini et al., 2001; Agrellos et al., 2003; Jones et al., 2004) . Galp residues can be sialylated through the direct transfer of sialic acid from host sialoglycoconjugates to the parasite mucins, a reaction catalyzed by a transsialidase activity on the parasite cell-surface (Previato et al., 1985; Schenckman, et al., 1991) .
There is strong evidence pointing to a role of trypomastigote mucins in host cell attachment, signaling and invasion (Burleigh and Andrews, 1995) . Antibodies to the carbohydrate moiety of mucins and the purified glycoprotein itself can inhibit host cell invasion by metacyclics (Acosta-Serrano et al., 2001) , whilst removal of sialic acid by treatment of these parasite forms with neuraminidase improves their Ca 2+ signaling capability and the ability to enter HeLa cells (Yoshida et al., 1997) . In addition, the dense negatively-charged coat provided by the sialylation of mucins is apparently important in protecting trypomastigotes from killing mediated by human anti -Gal antibodies (Pereira-Chioccola et al., 2000) .
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Besides mucins, other Gal-containing molecules, such as free GIPL and the main parasite cysteine protease (cruzipain), have also been implicated in infection and/or immunomodulation in the mammalian host (DosReis et al., 2002; Previato et al., 2004; Scharfstein, 2003) .
The biosynthesis of galactosylated molecules in T. cruzi relies exclusively on the utilization of Glc as the starting point for the generation of UDP-Gal. This unique characteristic arises from the fact that the T. cruzi hexose transporter (TcrHT1) of trypanosomes does not transport D-Gal (Tetaud et al., 1997) , so the parasite is unable to take up Gal from the extracellular environment and metabolize it through the Leloir pathway (Leloir, 1951) . Of the four enzymes that constitute the Leloir pathway, only the UDP-Gal-4-epimerase, encoded by GALE gene, has been characterized in T. cruzi (Roper and Ferguson, 2003) . In T.
brucei, the removal of tetracycline from a tetracycline-inducible conditional GALE null mutant was lethal, providing evidence that Gal metabolism is essential for the African trypanosomes (Roper et al., 2002; 2005) . Phosphoglucomutase (PGM, EC 5.4.2.2) is a key enzyme in carbohydrate metabolism interconverting Glc-6-P and Glc-1-P. Reaction of Glc-1-P with UTP forms the UDP-Glc, which is the substrate for the generation of UDP-Gal. PGM is ubiquitous in nature and highly conserved between species (Whitehouse et al., 1998; Schakelford et al., 2004) . The activity of PGM can be attributed to that of at least two closely related isoforms (PGM1 and PGM2) encoded by different genes (Tsoi and Douglas, 1964; Bevan and Douglas, 1969; Oh and Hopper, 1990) . A S. cerevisiae null mutant strain lacking both PGM genes (pgm1 /pgm2 ) is not viable when the cells are exposed to Gal as the sole carbon source (Daran et al., 1997) , while a yeast pgm2 strain display retarded growth and a large increase in Ca 2+ uptake and accumulation (Fu et al., 2000) . It was latter shown that PGM activity is important to maintain intracellular Ca 2+ homeostasis in yeast because the relative levels of Glc-6-P and of Glc-1-P are directly coupled to the processes of Ca 2+ uptake and storage (Aiello et al., 2002) .
Since the early studies aiming at the characterization of different T. cruzi stocks through isoenzyme patterns, PGM was a marker to differentiate populations belonging to three distinct parasite sub-groups or Zymodemes (Miles et al., 1980) . Recently, the use of additional molecular markers allowed T. cruzi strains to be divided into two major groups standardized as T. cruzi I, containing strains which are associated with the sylvatic cycle, and T. cruzi II, strains which are associated with the domestic cycle and are mainly involved in human infection (Souto et al., 1996; Luquetti et al., 1999) . However, T. cruzi PGM has never been characterized at the molecular and functional level.
In this study, we describe the cloning and molecular characterization of the PGM gene that encodes the T. cruzi PGM and show its activity by functional heterologous complementation of a S.
cerevisiae pgm1 /pgm2 mutant. We show that T. cruzi PGM rescues the yeast pgm1 /pgm2 lethal phenotype induced by growth in the presence of Gal.
Results

Cloning and characterization of the PGM gene of T. cruzi
Considering that PGM may be essential for Gal metabolism in T. cruzi, we decided to clone its PGM gene and undertake functional studies of the enzyme. As the complete sequence of the T. cruzi genome was not available when we started this study, we used a combination of complementary and degenerate oligonucleotides as primers in PCR reactions to obtain the partial sequence of the PGM gene. An and nt 1, respectively). In order to isolate the full-length PGM gene, we used the complementary primers LP5 and LP7 in a gene amplification reaction of genomic DNA that resulted in a single 1.8 kb fragment
( Figure 1 ). The genomic organization of the PGM gene was evaluated by Southern blot using probes directed to the 5' (515 bp) and 3' (360 bp) ends of the PGM ORF, and the results presented in Figure 2A and B, respectively. A single hybridization fragment was detected when endonucleases that do not cut in the PGM gene were used, and the size of each fragment was used to build up a physical map of the T.
cruzi PGM gene genomic organization ( Figure 2D ). These results suggest that the PGM gene is present as a single copy per haploid genome. Northern blotting analysis of two life stages of T. cruzi revealed that PGM RNA of the expected size (~1.8 kb) is present at similar levels in both epimastigote and trypomastigote forms ( Figure 2C , arrow).
In contrast to other eukaryotes, the 5' end of fully processed mRNA of protein encoding genes of trypanosomatids such as T. cruzi contain an identical 39-nucleotide named the mini-exon sequence which derives from a larger RNA, and is transferred to the 5'-end of each mRNA by trans-splicing (Bergmeyer, 1986; Boothroyd and Cross, 1982) . At the 5' end of the PGM gene, we identified several putative transsplicing "ag" acceptor sites preceding the first predicted start codon and two of them preceding the second predicted start codon ( Figure 1 , italics underlined). Therefore, both start codons could possibly be used for the translation of PGM.
In order to identify the trans-splicing site in the mRNA of T. cruzi PGM, we used total RNA isolated from epimastigotes of Dm28c T. cruzi for the synthesis of cDNA, which was subsequently 7 submitted to PCR with a primer directed to the mini-exon sequence as forward and the PGM AA160 primer as reverse ( Figure 3A ). The sequence of the resulting fragment (520 bp) revealed a single product containing part of the mini-exon sequence ( Figure 3A , bold) fused to PGM, indicating that the transsplicing site was located 18 nucleotides upstream from the second predicted start codon ( Figure 3A , arrowhead). We assumed that if small amounts of cDNA corresponding to RNA molecules processed at the first putative trans-splicing acceptor site were present, they might not be detected in the agarose gel of the RT-PCR. However, these minor products might be identified by a more sensitive technique, such as hybridization with radio labeled probes. To confirm that the other predicted trans-splicing acceptor sites
were not used to generate a processed RNA, we submitted the resulting fragments of the RT-PCR to hybridization with radio labeled oligonucleotides LP5 and LP6 directed to both start codons ( Figure 1 ).
Positive hybridization was only observed with LP6, and cDNA containing the region between the first two putative trans-splicing acceptor sites could not be detected ( Figure 3B ). Collectively, these results suggest that the second putative start codon is the main site used for the synthesis of PGM.
Two PGM sequences showing low polymorphism were found in the sequence data of the T. cruzi cerevisiae (Table I) . The multiple alignment of T. cruzi PGM predicted amino acid sequence with that of different organisms revealed that the amino acids that compose the enzyme`s active site were conserved, as expected (Figure 1 , amino acids in reverse-type).
Functional complementation of pgm1 /pgm2 S. cerevisiae with T. cruzi PGM
To verify if the T. cruzi PGM gene encodes a functional enzyme, we analyzed its ability to complement the phenotype of a S. cerevisiae PGM null mutant. The complete coding sequence of T. cruzi PGM was expressed in both wild-type yeast (JM245) and in a pgm1 /pgm2 mutant (JM645) using the pYES 2.0 expression vector that uses the GAL1-promoter to drive insert expression which is induced by shifting the transformed cells to Gal-containing medium. The mutant strain is incapable of metabolizing Gal and presents a lethal phenotype when Gal is used as the sole carbon source (Daran et al., 1997) . As expected, wild type S. cerevisiae bearing the plasmid alone or T. cruzi-PGM grew normally in the presence of Gal 
T. cruzi PGM activity in S. cerevisiae
The activity of T. cruzi PGM was assayed in the homogenates of S. cerevisiae cells expressing the parasite enzyme, at different induction time intervals ( Figure 5A ). Maximum activity was detected after 12 h of induction, and we observed higher activity in homogenates of yeast pgm1 /pgm2 mutant expressing T. 
Discussion
We cloned the PGM gene of T. cruzi Dm28c by PCR using a combination of degenerate and specific primers. PGM is encoded by a single copy gene that is transcribed in at least two parasite life stages, epimastigote and trypomastigote. In S. cerevisiae, there are two genes encoding PGM iso-enzymes, PGM1 and PGM2 (Tsoi and Douglas, 1964; Bevan and Douglas, 1969; Oh and Hopper, 1990 Comparison of the Dm28c parasite strain PGM gene and the two CL Brener strain PGM sequences deposited in the GenBank™ revealed very few non-conservative amino acid changes (Figure 1 ).
Molecular typing of these strains has assigned Dm28c to T. cruzi group II while CL Brener represents a hybrid strain, possibly bearing alleles typical of both groups I and II (Souto et al., 1996; Luquetti et al., 1999) . PGM has been used in the past in multiple loci isoenzyme electrophoresis (MLEE) as a criterion to separate T. cruzi strains into different groups (Miles et al., 1980) . It is noteworthy that 2 and 5 amino acid substitutions found between Dm28 and the Tc00.1047053508637.90 and Tc00.1047053511911.130 CL Brener PGM sequences would introduce changes in charge that could contribute to the difference in the enzyme electrophoretic mobility observed by MLEE.
As expected, the majority of the amino acid substitutions encountered between S. cerevisiae and T. cruzi PGM lies outside of the regions that compose the active site, suggesting that these changes should not significantly affect enzyme activity. In agreement with that, T. cruzi PGM, when overexpressed from a high copy number episome, was able to complement the lethal phenotype displayed by S. cerevisiae pgm1 /pgm2 mutant when grown in the presence of D-Gal.
S. cerevisiae pgm2 mutant displays numerous phenotypes related to altered Ca 2+ homeostasis when D-Gal is used as the carbon source (Fu et al., 2000) . These alterations, e.g. a large increase in Ca 2+ uptake and accumulation were attributed specifically to the increased level of Glc-1-P in these cells. It was also suggested that slow growth of S. cerevisiae pgm2 mutant is partially due to Ca + stress rather than to a limitation in the rate of conversion of Glc-1-P to Glc-6-P (Fu et al., 2000) . Increased Ca 2+ uptake and accumulation are not observed when the relative ratio of Glc-6-P and Glc-1-P is restored by deleting the phosphofructokinase -subunit to increase Glc-6-P levels (Aiello et al., 2002) . More recently, however, it was verified that the increase of Ca 2+ uptake and accumulation observed in the S. cerevisiae pgm2 mutant is suppressed by disruption of the PMC1 gene which encodes the vacuolar Ca 2+ -ATPase, suggesting that phenotypic modifications observed when the yeast pgm2 strain is grown with Gal as the carbon and energy source are due to an imbalance in the distribution of Ca 2+ into different intracellular compartments, resulting to the relative levels of Glc-1-P and Glc-6-P (Aiello et al., 2004) . In T. cruzi, PGM may also play an important role in regulating Ca 2+ homeostasis. As in other eukaryotes, T. cruzi mobilizes intracellular Ca 2+ stores when interacting with certain types of mammalian cells in vitro and is a requisite for host cell invasion by these parasites (Neira et al., 2002) .
Materials and methods
Parasite cultures
Epimastigotes of T. cruzi Dm28c were cultivated in liver infusion-tryptose (LIT) medium supplemented with 10 % fetal bovine serum at 28 °C (Previato et al., 1998) . Tissue culture trypomastigotes were obtained from the supernatant of infected LLC-MK2 cells cultivated in Dulbeco's Modified Eagle`s medium, supplemented with 2 % fetal calf serum in a 5 % CO 2 humidified atmosphere at 37 °C (Previato et al., 1998) .
Cloning of the T. cruzi PGM gene
A partial sequence of the T. cruzi PGM gene was amplified by polymerase chain reaction ( kb PCR product was gel-purified using GenecleanII kit (BIO 101), ligated into the pCR2.1 TOPO vector (Invitrogen) and sequenced in a Perkin-Elmer ABI PRISM TM 3100 automated sequencer. The predicted amino acid sequence was compared with the translated PGM sequences from different organisms using the BLAST program and the sequences were aligned using Clustal W (Thompson et al., 1994) with default parameters. The PGM ORF was sub-cloned into the EcoRI/XhoI sites of the Invitrogen S.
cerevisiae expression vector pYES2.0.
Southern blot
Genomic DNA from T. cruzi Dm28c was extracted according to the proteinase K method (Blaxter et al., 1988) and 15 µg were digested with selected restriction endonucleases (AccI, BamHI, EcoRI, HindIII, PstI, SmaI and XbaI) at 37 °C for 18 h. The DNA was precipitated with ethanol-acetate, resolved in an 0.8 % (w/v) agarose gel and transferred to a positively charged nylon membrane (Hybond N + , Amersham Biosciences) in 0.4 N NaOH, 1 M NaCl overnight. After neutralization with 500 mM Tris-HCl, pH 7.5, 1 M NaCl and baking at 80 0 C, the membrane was blocked in 6x SSPE (900 mM NaCl, 60 mM NaH 2 PO 4 , 6 mM EDTA), 5x Denhardt's solution (Sigma), 1 % (w/v) Sarcosyl, and 100 µg.ml -1 salmon sperm DNA (Sigma) (blocking buffer), for 1 h at 55 0 C. The probe corresponding to a 360 bp fragment containing part of the 3'-end of the coding sequence of T. cruzi CL Brenner strain PGM gene (clone TENU2518, kindly provided by Dr. Lena Aslund, University of Upsala, Sweeden) was isolated after digestion with
HindIII/AccI, gel purified, radio labeled using [ -32 P]dCTP and the Rad Prime DNA labeling system (Invitrogen), and used as a probe overnight, in blocking buffer at 55 0 C. A separate membrane was probed in the same conditions using a radio labeled 515 bp fragment corresponding to the 5'-coding sequence of PGM, obtained by PCR using primers LP5 and AA160. PCR conditions were the same as before, except 13 the annealing temperature that was at 55 o C. After hybridization, the membranes were washed twice in 0.1x SSC (15 mM NaCl, 1.5 mM sodium citrate), 0.1 % (w/v) SDS at 55ºC for 15 min, dried and exposed to X-ray films (X-OMAT LS, Kodak) with intensifying screens at -70 0 C for 24 h.
Northern blot
Total T. cruzi RNA from 10 8 cells was extracted using TRIzol® (Invitrogen), according to manufacturer's instructions. Samples of RNA (15 µg) were separated in 1.2% (w/v) formaldehyde agarose gel and tranferred to Hybond N + nylon membrane in 10x SSC overnight. After baking, the membrane was submitted to blocking in 50 mM phosphate buffer, pH 7.0, 5x SSC, 50 % (v/v) formamide, containing 100 µg.ml -1 sperm salmon DNA, 50x Denhardt's solution at 42 0 C, followed by hybridization with [ activity of PGM in S. cerevisiae extracts was assessed as previously described (Blaxter et al., 1988) .
Briefly, the extracts (50 µg.ml
) were incubated in 50 mM Tris-HCl, pH 7.5, 1 mM MgCl 2 , 0.5 mM NADP + supplemented with 5 U.ml -1 of Glc-6-P dehydrogenase (Sigma) and 4 mM Glc-1-P. Initial rates of product formation were determined by measuring the formation of NADPH, as assessed by the change in absorbance at 340 nm over time.
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